메뉴 건너뛰기
Acta Neuropsychiatrica
Volumn 10, Issue 3, 1998, Pages 78-79
Olanzapine as medication of first choice in therapy resistant schizophrenia?
Author keywords

Olanzapine; Therapy resistant schizophrenia
Indexed keywords

BIPERIDEN; CLOZAPINE; FLUPENTIXOL; HALOPERIDOL; OLANZAPINE; PAROXETINE;
EID: 0031662295     PISSN: 09242708     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0924270800036620     Document Type: Article
Times cited : (2)
References (7)
  • 1
    • 0025633831 scopus 로고
    • Defining treatment refractoriness in schizophrenia
    • Brenner HD, Dencker SJ, Goldstein MJ, et al. Defining treatment refractoriness in schizophrenia. Schizophr Bull 1990; 16: 551-62.
    • (1990) Schizophr Bull , vol.16 , pp. 551-562
    • Brenner, H.D.1    Dencker, S.J.2    Goldstein, M.J.3
  • 2
    • 0001615607 scopus 로고
    • Adverse event profile and safety of clozapine
    • Dev VJ, Krupp R. Adverse event profile and safety of clozapine. Rev contemp Pharmacother 1995; 6: 197-207.
    • (1995) Rev Contemp Pharmacother , vol.6 , pp. 197-207
    • Dev, V.J.1    Krupp, R.2
  • 3
    • 0029930337 scopus 로고    scopus 로고
    • Olanzapine versus placebo: Results of a double-blind fixed dose olanzapine trial
    • Beasley CM, Sanger T, Satterlee W, et al. Olanzapine versus placebo: results of a double-blind fixed dose olanzapine trial. Psychopharmacology 1996; 124: 159-67.
    • (1996) Psychopharmacology , vol.124 , pp. 159-167
    • Beasley, C.M.1    Sanger, T.2    Satterlee, W.3
  • 4
    • 0030065502 scopus 로고    scopus 로고
    • Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial
    • Beasley CM, Tollefson G, Tran P, et al. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 1996; 14: 111-24
    • (1996) Neuropsychopharmacology , vol.14 , pp. 111-124
    • Beasley, C.M.1    Tollefson, G.2    Tran, P.3
  • 5
    • 0030993030 scopus 로고    scopus 로고
    • Olanzapine versus haloperidol in treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial
    • Tollefson GD, Beasley CM, Tran PV, et al. Olanzapine versus haloperidol in treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiat 1997; 154: 457-65.
    • (1997) Am J Psychiat , vol.154 , pp. 457-465
    • Tollefson, G.D.1    Beasley, C.M.2    Tran, P.V.3
  • 6
    • 0030758764 scopus 로고    scopus 로고
    • Intermittent neuroleptic treatment of therapy-resistant schizophrenic psychoses
    • Campo J, à, Nijman H, Merckelbach H. Intermittent neuroleptic treatment of therapy-resistant schizophrenic psychoses. Eur J Psychiat 1997; 11: 69-71.
    • (1997) Eur J Psychiat , vol.11 , pp. 69-71
    • Campo, J.À.1    Nijman, H.2    Merckelbach, H.3
  • 7
    • 0003472161 scopus 로고
    • Department of Psychiatry, Albert Einstein College of Medicine, Montefiore Medical Centre, and Schizophrenia Research Unit, Bronx Psychiatric Centre
    • Kay SR, Opler LA, Fiszbein A. Positive and negative syndrome scale (PANSS) rating manual. Department of Psychiatry, Albert Einstein College of Medicine, Montefiore Medical Centre, and Schizophrenia Research Unit, Bronx Psychiatric Centre, 1986.
    • (1986) Positive and Negative Syndrome Scale (PANSS) Rating Manual
    • Kay, S.R.1    Opler, L.A.2    Fiszbein, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.